I'd like to know what CEO after CEO has been in talks about. You'd think after all this time someone would have found someone who was willing to take a little gamble. We've seen deals where BP is paying hundreds of millions for techniques, for drugs not even developed yet. Sure this is an oddity, yet we see little interest beyond rumor, postings in here and King's "We're in talks" to show any interest in Peregrine. Whoops, I forgot this Duke thing with rat and maybe monkey data. We're in human trials and posters expect lab data to have a better market reaction. IF everyone knows about Peregrine and Duke then they already know what's happening and the long awaited papers mean little IMO..
Market Data 
Markets 
AI
